Yanfen Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yanfen Liu has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Jun Liu
Department of Internal Medicine, Shaxi People’s Hospital, Taicang, China
1 shared publication - Xueyong Lou
Jinhua Municipal Central Hospital, Department of Endocrinology Jinhua, 321000, China
1 shared publication - Xueyong Lou
Department of Endocrinology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China
1 shared publication
Latest Publications
- Open Access
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47268
Dissecting the causal link between transient hypoglycemic coma and gut-brain axis imbalance – implications for diarrhea pathogenesis: A case report
Rationale: The systemic consequences of hypoglycemic brain injury beyond the central nervous system remain poorly understood. While the brain-gut axis is a pivotal communication network, clinical evidence linking hypoglycemia to gut dysmotility is confounded by comorbidities like autonomic neuropathy. This case report aims to present the first documented evidence of isolated hypoglycemic brain injury inducing transient, profound diarrhea through a hypothesized brain-gut pathway, in a patient with all confounding factors rigorously excluded and premorbid normal gut histology. Patient concerns: A 65-year-old male with type 2 diabetes suffered an insulin overdose, resulting in profound hypoglycemia (glucose 1.8 mmol/L) and a 10-minute comatose state. Twenty-four hours post-hypoglycemia, he developed acute-onset, large-volume watery diarrhea (3–4 episodes daily). Diagnoses: A comprehensive diagnostic workup excluded all common infectious, inflammatory, autoimmune, metabolic, and structural causes. Interventions: The diarrhea proved refractory to a sequential therapeutic regimen including loperamide, smectite, Saccharomyces boulardii, and cholestyramine. Outcomes: The symptoms persisted unabated until their abrupt and complete resolution on day 11, without therapeutic intervention. At 3-month follow-up, the patient remained asymptomatic with normal bowel function and objective tests. Lessons: This case illuminates a novel, self-limiting cerebro-enteral pathway activated by hypoglycemia, which we hypothesize is mediated by blood–brain barrier-disruption and corticotropin-releasing hormone-driven neurohumoral cascades. It underscores the need to consider central nervous system injury in the differential diagnosis of unexplained acute diarrhea and highlights the necessity for monitoring gastrointestinal symptoms post-hypoglycemia.
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47268
Open AccessDissecting the causal link between transient hypoglycemic coma and gut-brain axis imbalance – implications for diarrhea pathogenesis: A case report
Rationale: The systemic consequences of hypoglycemic brain injury beyond the central nervous system remain poorly understood. While the brain-gut axis is a pivotal communication network, clinical evidence linking hypoglycemia to gut dysmotility is confounded by comorbidities like autonomic neuropathy. This case report aims to present the first documented evidence of isolated hypoglycemic brain injury inducing transient, profound diarrhea through a hypothesized brain-gut pathway, in a patient with all confounding factors rigorously excluded and premorbid normal gut histology. Patient concerns: A 65-year-old male with type 2 diabetes suffered an insulin overdose, resulting in profound hypoglycemia (glucose 1.8 mmol/L) and a 10-minute comatose state. Twenty-four hours post-hypoglycemia, he developed acute-onset, large-volume watery diarrhea (3–4 episodes daily). Diagnoses: A comprehensive diagnostic workup excluded all common infectious, inflammatory, autoimmune, metabolic, and structural causes. Interventions: The diarrhea proved refractory to a sequential therapeutic regimen including loperamide, smectite, Saccharomyces boulardii, and cholestyramine. Outcomes: The symptoms persisted unabated until their abrupt and complete resolution on day 11, without therapeutic intervention. At 3-month follow-up, the patient remained asymptomatic with normal bowel function and objective tests. Lessons: This case illuminates a novel, self-limiting cerebro-enteral pathway activated by hypoglycemia, which we hypothesize is mediated by blood–brain barrier-disruption and corticotropin-releasing hormone-driven neurohumoral cascades. It underscores the need to consider central nervous system injury in the differential diagnosis of unexplained acute diarrhea and highlights the necessity for monitoring gastrointestinal symptoms post-hypoglycemia.
- Open Access
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges
The gut microbiota is a group of over 38 trillion bacterial cells in the human microbiota that plays an important role in the regulation of human metabolism through its symbiotic relationship with the host. Changes in the gut microbial ecosystem are associated with increased susceptibility to metabolic disease in humans. However, the composition of the gut microbiota in those with type 2 diabetes mellitus and in the pathogenesis of metabolic diseases is not well understood. This article reviews the relationship between environmental factors and the gut microbiota in individuals with type 2 diabetes mellitus. Finally, we discuss the goal of treating type 2 diabetes mellitus by modifying the gut microbiota and the challenges that remain in this area.
Open AccessType 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges
The gut microbiota is a group of over 38 trillion bacterial cells in the human microbiota that plays an important role in the regulation of human metabolism through its symbiotic relationship with the host. Changes in the gut microbial ecosystem are associated with increased susceptibility to metabolic disease in humans. However, the composition of the gut microbiota in those with type 2 diabetes mellitus and in the pathogenesis of metabolic diseases is not well understood. This article reviews the relationship between environmental factors and the gut microbiota in individuals with type 2 diabetes mellitus. Finally, we discuss the goal of treating type 2 diabetes mellitus by modifying the gut microbiota and the challenges that remain in this area.